1. Home
  2. PDLB vs STRO Comparison

PDLB vs STRO Comparison

Compare PDLB & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ponce Financial Group Inc.

PDLB

Ponce Financial Group Inc.

HOLD

Current Price

$20.21

Market Cap

492.0M

Sector

N/A

ML Signal

HOLD

Logo Sutro Biopharma Inc.

STRO

Sutro Biopharma Inc.

HOLD

Current Price

$16.03

Market Cap

332.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PDLB
STRO
Founded
1960
2003
Country
United States
United States
Employees
216
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
492.0M
332.8M
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
PDLB
STRO
Price
$20.21
$16.03
Analyst Decision
Buy
Analyst Count
0
9
Target Price
N/A
★ $31.33
AVG Volume (30 Days)
63.7K
★ 296.1K
Earning Date
04-24-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 160.87
N/A
EPS
★ 0.71
N/A
Revenue
N/A
★ $38,419,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$28.65
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$13.91
$0.72
52 Week High
$21.10
$43.85

Technical Indicators

Market Signals
Indicator
PDLB
STRO
Relative Strength Index (RSI) 47.03 30.44
Support Level $20.11 $14.81
Resistance Level $20.74 $17.33
Average True Range (ATR) 0.33 1.05
MACD -0.03 0.09
Stochastic Oscillator 23.19 22.32

Price Performance

Historical Comparison
PDLB
STRO

About PDLB Ponce Financial Group Inc.

Ponce Financial Group Inc, is a United States-based holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in mortgage loans, consisting of one-to-four-family residential, multi-family residential, non-residential property and construction and land, and, to a lesser extent, business, and consumer loans. The company also invests in securities, which consists of securities issued by the U.S. Government and federal agencies and mortgage-backed securities issued by the United States government-sponsored enterprises. Some of the products and services include checking solutions, online and mobile banking, merchant credit card services, and others.

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. Company's wholly-owned product candidate is STRO-004, a single homogeneous ADC directed against tissue factor which are developing for the treatment of solid tumors. The company also pipeline contains STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

Share on Social Networks: